Di Vito Anna, Mele Maria, Piscioneri Antonella, Morelli Sabrina, Bartolo Loredana De, Barni Tullio, Facciolo Rosa Maria, Canonaco Marcello
Molecular Oncology Laboratory, Experimental and Clinical Medicine Department, University Magna Graecia of Catanzaro, 88100, Catanzaro, Italy,
Cell Mol Neurobiol. 2014 May;34(4):501-9. doi: 10.1007/s10571-014-0034-0. Epub 2014 Feb 16.
It's known that neurons in mammalian hibernators are more tolerant to hypoxia than those in non-hibernating species and as a consequence animals are capable of awakening from the arousal state without exhibiting cerebral damages. In addition, evidences have suggested that euthermic hamster neurons display protective adaptations against hypoxia, while those of rats are not capable, even though molecular mechanisms involved in similar neuroprotective strategies have not been yet fully studied. In the present work, overstimulation of glutamatergic receptors NMDA recognized as one of the major death-promoting element in hypoxia, accounted for altered network complexity consistent with a moderate reduction of hippocampal neuronal survival (p < 0.05) in hamsters. These alterations appeared to be featured concomitantly with altered glutamatergic signaling as indicated by significant down-regulation (p < 0.01) of NMDAergic (NR2A) and AMPAergic (GluR1, R2) receptor subtypes together with the metabotropic mGluR5 subtype. Diminished mRNA levels were also reported for NMDA receptor binding factors and namely PSD95 plus DREAM, which exert positive and negative regulatory properties, respectively, on receptor trafficking events. Conversely, involvement of glutamatergic signaling systems on neuronal excitotoxicity was strengthened by the co-activation of GABAAR-mediated effects as indicated by toxic morphological effects being notably reduced along with up-regulated GluR1, GluR2, mGluR5, DREAM, and Homer1c scaffold proteins when muscimol was added. Overall, these results point to a neuroprotective role of the GABAergic system against excitotoxicity episodes via DREAM-dependent inhibition of NMDA receptor and activation of AMPA receptor plus mGluR5, respectively, thus proposing them as novel therapeutic targets against cerebral ischemic damages in humans.
已知哺乳动物冬眠者的神经元比非冬眠物种的神经元对缺氧更具耐受性,因此动物能够从觉醒状态苏醒而不表现出脑损伤。此外,有证据表明,恒温仓鼠神经元对缺氧表现出保护性适应,而大鼠神经元则不具备这种能力,尽管参与类似神经保护策略的分子机制尚未得到充分研究。在本研究中,谷氨酸能受体NMDA被认为是缺氧时主要的促死亡因素之一,其过度刺激导致网络复杂性改变,这与仓鼠海马神经元存活率适度降低(p<0.05)一致。这些改变似乎与谷氨酸能信号改变同时出现,表现为NMDA能(NR2A)和AMPA能(GluR1、R2)受体亚型以及代谢型mGluR5亚型显著下调(p<0.01)。NMDA受体结合因子,即PSD95和DREAM的mRNA水平也降低,它们分别对受体转运事件发挥正向和负向调节作用。相反,当加入蝇蕈醇时,GABAAR介导的效应共同激活增强了谷氨酸能信号系统对神经元兴奋性毒性的影响,表现为毒性形态学效应显著降低,同时GluR1、GluR2、mGluR5、DREAM和Homer1c支架蛋白上调。总体而言,这些结果表明GABA能系统通过分别依赖DREAM抑制NMDA受体和激活AMPA受体加mGluR5对兴奋性毒性发作具有神经保护作用,因此提出它们作为人类脑缺血损伤的新型治疗靶点。